Schedule 13D ownership disclosure
AERIE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00771V108
Event date: 2015-06-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,237,466
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-15-000395
- Form type
- SC 13D
- Filer
- AERIE PHARMACEUTICALS INC
- CIK
- CIK 1337553
- Filed
- Jun 22, 2015
- Reporting period
- Jun 19, 2015
- Description
- Schedule 13D beneficial ownership